Drug Discovery Today

DECEMBER 21, 2021

Lab Innovations, the UK’s largest trade exhibition for the laboratory industry, returned to the NEC, Birmingham, on November 3 and 4, 2021 and brought the laboratory community together for the first time after almost two years apart. With 3,117 visitors, the show gave the industry’s leading professionals and companies the chance to meet face-to-face, network and discover the latest innovations.

Laboratories 113

Laboratories 113

Drug Patent Watch

DECEMBER 22, 2021

Annual Drug Patent Expirations for CORLANOR Corlanor is a drug marketed by Amgen Inc and is included in two NDAs. It is available from one supplier. There are eight patents…. The post New patent for Amgen Inc drug CORLANOR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Drug Channels

DECEMBER 13, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. Click here to see the original post and comments from August 2021. The generic prescription market is being disrupted—but not by the big, bad spaceman from Seattle. Instead, consider how GoodRx is affecting patients, payers, and PBMs.

Pharmacy 98

Pharmacy Marketing Drugs 98

Eye on FDA

DECEMBER 15, 2021

The COVID-19 pandemic is a rapidly changing landscape. We are long gone from the days of being threatened by a rampant Alpha virus to having several successive variants. It now appears that the very fast-spreading Omicron may become dominant over yesterday’s Delta variant. We now have multiple vaccines – mRNA and traditional in the U.S. and an even greater array outside the U.S.

Vaccine 72

Vaccine Nurses Virus Treatment 72

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Policy Prescription

DECEMBER 22, 2021

UPDATE : Senator Amy Klobuchar (D-MN) has withdrawn her sponsorship and support for this bill. A new bill introduced by Sens. Mark Rubio (R-FL) and Amy Klobuchar (D-MN) , called the “Domain Reform for Unlawful Drug Sellers Act’’ or, for short, the ‘‘DRUGS Act,’’ could effectively end online access to safe and affordable imported medicines for Americans.

Online Pharmacies 52

Online Pharmacies Pharmacy International Drugs 52

Olympian Clinical Research

DECEMBER 22, 2021

Headaches are one of the most common medical complaints and can range from mild to severe. But how do you know if the pain in your head is from a headache or something more serious? Many people struggle to differentiate between a typical headache and a migraine, which is a chronic headache disorder. What is a Headache? A headache is a condition that causes pain in the head, face, or neck, and there are more than 150 types, falling into two main categories: primary and secondary headaches. .

Clinical Research 52

Clinical Research Clinical Trials Trials Research 52

Drug Patent Watch

DECEMBER 9, 2021

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Drug Channels

DECEMBER 19, 2021

Happy New Year, everyone! We made it through a challenging 2021. Ring in 2022 with these noisemakers from the Drug Channels party bag: Hospitals earn incredible markups on CAR-T therapies Utilization management booms Health plans often ignore clinical guidelines Benefit designs flummox physicians Plus: an awesomely concise summary of U.S. health insurance.

Hospitals 98

Hospitals Therapies Drugs 98

Pharmaceutical Development Group

DECEMBER 19, 2021

Start Up and Generic Pharmaceutical Drug and Biologic Companies have high quality, affordable products that improve the quality of life for their patients. However, this often is associated with austere conditions wherein time and funds are both in short supply. Effective use of Real World Data (RWD) and Real World Evidence (RWE) can reduce costs of Pharmaceutical Drug and Biologic Products and Process Development, Drug Development Services , expedite a FDA Pre-Submission Review, and lead to FDA

FDA Approval 52

FDA Approval FDA Clinical Trials Drug Development 52

Crown Bioscience

DECEMBER 16, 2021

In this post, we explore the differences between the terms high-content imaging (HCI), high-content screening (HCS), and high-content analysis (HCA), and why these automated and image-based high-throughput technologies are increasingly being adopted to generate data to facilitate preclinical studies and downstream go/no-go decision-making.

52

52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

ProRelix Research

DECEMBER 15, 2021

­­Drug development strategy for US FDA It takes a staggering 12 years on an average for a drug to travel from the laboratory bench to your bedside! This is coupled […]. The post Drug development strategy for US FDA appeared first on ProRelix Research.

Drug Development 52

Drug Development FDA Laboratories Drugs 52

Drug Discovery Today

DECEMBER 23, 2021

Directing Strategy, Decision Making and Resource Optimization for Optimal Portfolio Success

100

100

Drug Patent Watch

DECEMBER 22, 2021

Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are sixteen patents…. The post New patent for Allergan Holdings drug VIBERZI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Drug Channels

DECEMBER 15, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. Click here to see the original post and comments from August 2021. Charlotte Morabito at CNBC has put together “Why Pharmacies Overcharge,” an entertaining and provocative video on the pharmacy industry and its generic prescription pricing.

Pharmacy 98

Pharmacy Drugs 98

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

The Strateos Blog: Drug Discovery

DECEMBER 13, 2021

SynBioBeta 2021 – the Global Synthetic Biology Conference – will take place between January 25th - 27th 2022 in Oakland, California. Strateos’ own Daniel Rines, Ph.D., Senior Director, R&D Strategy, will be delivering a presentation highlighting how Strateos' smart lab platform accelerated riboswitch engineering to develop novel biosensors.

Engineering 52

Engineering Protein Expression Research Laboratories RNA 52

EG Life Sciences

DECEMBER 6, 2021

For some time, Eliassen Group and EG Life Sciences have been working together to tackle the challenges faced by pharmaceutical companies as they innovate to keep up with a rapidly changing landscape. As part of that, we have invited members of the pharmaceutical industry and Agile experts to lean coffees that discuss ways to bring Agile and biopharma together to speed up delivery, unlock operational excellence, and improve lives.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies Science 52

The Pharma Data

DECEMBER 3, 2021

In the zuranolone 50 mg cohort, the majority of patients who responded to an initial 14-day course received only one two-week course of treatment during the study and nearly 80% received only one or two treatment courses in total. Zuranolone 50 mg was generally well-tolerated with an overall adverse event profile consistent with data reported earlier and 6.5% of patients discontinuing study drug due to adverse events.

Biosimilars 52

Biosimilars Treatment Disease Clinical Trials 52

Drug Discovery Today

DECEMBER 24, 2021

Leveraging AI to Accelerate the Path From Diagnosis to Cure

100

100

Drug Patent Watch

DECEMBER 17, 2021

Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from one supplier. There are eighteen…. The post New patent for Acadia Pharms drug NUPLAZID appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Drug Channels

DECEMBER 16, 2021

This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: Drug Channels Outlook 2022. Hope you can join me! Click here to see the original post and comments from September 2021. Cardinal Health recently released the annual report for its 2021 fiscal year, which ended on June 30. See the links below. Today, I delve into the financials behind Cardinal’s relationship with its largest customer, CVS Health.

Pharmaceuticals 98

Pharmaceuticals Drugs Pharmacy 98

Sygnature Discovery

DECEMBER 17, 2021

2021 is nearly over – and what a year it’s been for Sygnature! From key appointments to new investment and growth across the pond, there have been plenty of reasons to get out the party poppers despite the ongoing pandemic (in a safe fashion, obviously). Let’s remind ourselves of a great 12 months… The successes started early when we were named Company of the Year at the slightly delayed 2020 Bionow Annual Awards in February.

Small Molecule 52

Small Molecule Laboratories Drugs Pharmaceuticals 52

PerkinElmer

DECEMBER 3, 2021

G-protein coupled receptors (GPCRs) are the largest and most diverse family of membrane receptors in the human genome and are targeted by around one third of drugs currently approved by the FDA. These proteins represent one of the most extensively studied targets for drug discovery, mainly due to their involvement in a plethora of signaling pathways and pathophysiological processes in the human body.

Drugs 52

Drugs Small Molecule Regulations Research 52

The Pharma Data

DECEMBER 4, 2021

TEL AVIV & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of an authorized generic of Epiduo® 1 Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the United States. Adapalene and benzoyl peroxide gel 0.3%/2.5% is a topical prescription medicine used to treat acne vulgaris.

Doctors 52

Doctors FDA FDA Approval Pharmaceuticals 52

The Strateos Blog: Drug Discovery

DECEMBER 13, 2021

We are excited to share that Strateos’ SVP of Strategy & Operations, Daniel Sipes, will be delivering a presentation entitled Accelerating Medicinal Chemistry Cycle Times Through Cloud-Accessible Smart Automated Labs at the upcoming 2022 Society for Laboratory Automation and Screening Conference & Exhibition between February 5-9th. SLAS 2022 is set to be an exciting conference where scientists can come together to learn about the innovative technologies transforming the way life s

Biochemical Assays 52

Biochemical Assays Small Molecule Laboratories Science 52

Drug Patent Watch

DECEMBER 16, 2021

Annual Drug Patent Expirations for XERAVA Xerava is a drug marketed by Tetraphase Pharms and is included in one NDA. There are two patents protecting this drug. This drug has…. The post New patent for Tetraphase Pharms drug XERAVA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Drug Channels

DECEMBER 17, 2021

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Drug Channels Outlook 2022. See you soon! Click here to see the original post and comments from September 2021. Sometimes, a little knowledge can be a bad thing. I want to share with you, dear reader, the strange but true tale of my recent foray into the wonderful world of hospital price transparency for routine lab services.

Hospitals 98

Hospitals Regulations Drugs 98

Olympian Clinical Research

DECEMBER 7, 2021

The clinical trial process can be a complicated but rewarding one. There are many different types of trials and even more ways to participate in them. Therefore, fully understanding the clinical trial process can help you get the most out of any study that you choose to participate in. What is a Clinical Trial? A clinical trial is a medical research study designed to provide data for new and existing treatment methods.

Clinical Trials 52

Clinical Trials Trials Clinical Research Treatment 52

Drug Patent Watch

DECEMBER 2, 2021

Annual Drug Patent Expirations for OXTELLAR+XR Oxtellar Xr is a drug marketed by Supernus Pharms and is included in one NDA. It is available from one supplier. There are nine…. The post New patent for Supernus Pharms drug OXTELLAR XR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Drug Channels

DECEMBER 7, 2021

It’s time for our annual deep dive into employer-sponsored coverage for prescription drugs. For 2021, employers backed away slightly from high-deductible health plans. However, their pharmacy benefit designs increased the use of coinsurance for specialty and fourth-tier drugs. These designs have significantly raised patients’ out-of-pocket obligations and are likely to have reduced adherence.

Pharmacy 98

Pharmacy Drugs 98

Drug Channels

DECEMBER 5, 2021

Better Data, Better Outcomes: A LexisNexis ® Risk Solutions and Q1 Productions Webinar. December 14, 2021 1:00 pm ET. This webinar is scheduled for a 45 minute presentation followed by 10 to 15 minutes of Q&A. Click here to register for this complimentary webinar. Your business depends on the data collected everyday across healthcare. That data not only drives the validation of the products and services your company offers today, but it also generates opportunities for new products and servi

Production 75

Production Science Drugs Research 75

Drug Channels

DECEMBER 2, 2021

Looking for a thoughtful and timely stocking stuffer? I suggest Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic , by Scott Gottlieb, M.D. (Amazon link). This book provides a comprehensive, well-written chronicle of the COVID-19 pandemic (as of mid-2021). Dr. Gottlieb documents—with great specificity—how and why our government’s public health infrastructure failed us during the pandemic.

Drugs 75

Drugs 75

Drug Patent Watch

DECEMBER 30, 2021

[![bortezomib structure]([link] Bortezomib is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Dr Reddys Labs Ltd, and Fresenius Kabi Usa and, and is included in three…. The post New tentative approval for Hospira Inc drug bortezomib appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

DECEMBER 29, 2021

Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…. The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

DECEMBER 27, 2021

Annual Drug Patent Expirations for ACCUNEB Accuneb is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There is one…. The post New patent expiration for Mylan Speciality drug ACCUNEB appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52